bryan johnson glp 1 Johnson's diagnosis shines light on hard-to-detect disease Comment “curious” for the full

Studies are also underway for a spectrum of other conditions, including Phase 3 trials investigating non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD), and obstructive sleep apnea (OSA), as well as mid-to-late stage trials exploring potential benefits in neurodegenerative disorders like Parkinsons disease

Ben attributes this to several factors: Proven effectiveness in clinical trials and real-world use Social media and press coverage showcasing dramatic weight loss stories Advances in drug delivery, including long-acting formulations and oral options Expanding indications beyond diabetes to include obesity treatment Were in a situation where its the right molecule at the right time, Ben notes

Anderberg RH, Richard JE, Eerola K, Ferreras LL, Nordbeck EB, Hansson C, et al

Step 2: The 4-Ounce Water Limit (And Why It Matters) While food is not recommended, some water is allowed but only in a small amount

But the mechanism is plausible, the timeline is consistent with a pharmacological cause, and the resolution upon medication change strongly supports the association

If you want Wegovy, Ozempic, or tirzepatide, you can upgrade (though at a higher cost)